Knight Therapeutics Inc

CIK 1756235 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Knight Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Jul 29, 2026SCHEDULE 13G0001213900-26-082794
Jul 29, 202630001213900-26-082796
May 15, 2026SCHEDULE 13G/A0001213900-26-057698
Jun 13, 202540001213900-25-054279
Jun 13, 2025SCHEDULE 13G/A0001213900-25-054289
Mar 20, 2025SCHEDULE 13G0001213900-25-025520
Nov 13, 2024SC 13G/A0001213900-24-097440
Oct 22, 202430001474506-24-000225
Apr 3, 202440001140361-24-017682
Dec 18, 202330001140361-23-058049
Feb 14, 2019SC 13G/A0001019056-19-000117
Oct 17, 2018SC 13G0001019056-18-001029